Hikma Pharmaceuticals (LON:HIK) Stock Price Crosses Above 200 Day Moving Average – Time to Sell?

Shares of Hikma Pharmaceuticals PLC (LON:HIK) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,922.34 ($24.05) and traded as high as GBX 2,002.90 ($25.06). Hikma Pharmaceuticals shares last traded at GBX 2,002.90 ($25.06), with a volume of 103,513 shares trading hands.

Hikma Pharmaceuticals Stock Up 1.0 %

The stock has a 50-day moving average price of GBX 1,914.86 and a 200-day moving average price of GBX 1,922.34. The company has a debt-to-equity ratio of 55.48, a current ratio of 1.66 and a quick ratio of 1.27. The company has a market capitalization of £4.44 billion, a P/E ratio of 3,081.38, a P/E/G ratio of 2.38 and a beta of 0.41.

Hikma Pharmaceuticals Company Profile

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.